{
  "trial_id": "NCT04637282",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age between 5 and 18 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Diagnosis of classic CLN3 disease",
      "label": "met",
      "evidence": "positive anti-AChR antibody test, single fiber electromyography (SFEMG) was positive"
    },
    {
      "criterion": "Mild-to-moderate CLN3 disease documented by the UBDRS",
      "label": "unknown",
      "evidence": "physical exam and lab studies were not remarkable for any other abnormalities"
    },
    {
      "criterion": "Participant must be able to independently walk for a distance of at least 20 feet (6 meters)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Participant must be able to tolerate swallowing oral medication or have a gastric/jejunostomy tube for drug administration",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Asymptomatic CLN3 disease",
      "label": "not_met",
      "evidence": "complains of diplopia and fatigue and weakness that affects mainly her upper limbs"
    },
    {
      "criterion": "Participant has clinically documented generalized motor status epilepticus within 4 weeks of the Baseline visit",
      "label": "unknown",
      "evidence": "physical exam and lab studies were not remarkable for any other abnormalities"
    }
  ],
  "notes": "The patient is a 35-year-old woman with myasthenia gravis, class IIa. She has symptoms that interfere with her job as a research coordinator.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT04637282",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}